SUBSCRIBE
SUBSCRIBE

Preclinical

Drug Development
Drug Offers Hope In Treating TB
October 19, 2005
 · 
1 min read
Drug Development
Anthrax Toxin Inhibitor Prevents Anthrax Infection In Animals
October 19, 2005
 · 
2 min read
Drug Development
New “Superaspirin” Prevents Colon Cancer In Mice
October 19, 2005
 · 
1 min read
Drug Development
Two Novel Agents Work Synergistically To Treat Lung Cancer In Animal Experiment
October 19, 2005
 · 
1 min read
Drug Development
Vaginal Gel May Protect Women From HIV
October 19, 2005
 · 
1 min read
Drug Development
Potential Arthritis Drug Falls Short; Animal Study Shows It Fails To Cut Long-Term Joint Pain
October 19, 2005
 · 
1 min read
Drug Development
Dendritic Cell Vaccine Quells GI Tumors In Mice
October 19, 2005
 · 
1 min read
Drug Development
Drug Firms Pledge More Cash For Animal Research
October 19, 2005
 · 
1 min read
Drug Development
Mice Grow Human Breast Tissue
October 19, 2005
 · 
1 min read
Drug Development
Antidote-reversible Anticoagulant Works In Animal Models Of Heart Disease
October 19, 2005
 · 
2 min read
Load More
PRESS RELEASES
Drug Development
Veto T-Cell Bone Marrow Transplant Safely Demonstrates Potential Cure for Sickle Cell Anemia in Preclinical Trials
March 12, 2021
 · 
6 min read
Drug Development
VistaGen’s PH10 Nasal Spray Demonstrates Different Mechanism of Action from Benzodiazepines in Preclinical Study
March 11, 2021
 · 
7 min read
Drug Development
Mitazalimab synergizes with chemotherapy - Alligator Bioscience presents new preclinical data at AACR
March 11, 2021
 · 
2 min read
Drug Development
Xencor to Present Preclinical Data from Four Preclinical XmAb® Bispecific Antibody and Cytokine Programs at the American Association for Cancer Research (AACR) Annual Meeting 2021
March 10, 2021
 · 
3 min read
Drug Development
Arch Oncology Announces Two New Preclinical Data Presentations on Highly Differentiated Anti-CD47 Antibody AO-176 at AACR 2021
March 10, 2021
 · 
4 min read
Drug Development
Merus Announces Poster Presentations for Zenocutuzumab and MCLA-129 at the American Association for Cancer Research 2021 Annual Meeting
March 10, 2021
 · 
5 min read
Drug Development
RAPT Therapeutics to Report Promising Preclinical Studies Supporting its Pipeline of Immunotherapy Platforms at AACR
March 10, 2021
 · 
6 min read
Drug Development
Relay Therapeutics to Present Preclinical Data on RLY-4008 at AACR Annual MeetingRLY-4008 demonstrates strong activity against known clinical on-target resistance mutations in cellular and in vivo preclinical models
March 10, 2021
 · 
4 min read
Drug Development
PMV Pharmaceuticals Announces Presentation of PC14586 Preclinical Data at the American Association for Cancer Research (AACR) Annual Meeting 2021
March 10, 2021
 · 
3 min read
Drug Development
Intellia Therapeutics Presents Preclinical Proof of Concept for CRISPR-based In Vivo Editing of Bone Marrow at Keystone eSymposium
March 10, 2021
 · 
7 min read
Drug Development
Capricor Therapeutics Announces New Advances in Exosome-Mediated mRNA Delivery Platform
March 9, 2021
 · 
5 min read
Drug Development
SciSparc to Commence a Pre-Clinical Study Using its SCI-210 Cannabidiol Based Treatment for Epilepsy
March 9, 2021
 · 
4 min read
Drug Development
Medolife Rx Announces Preclinical Trial Results From Toxicity Study on Lead Drug Candidate
March 9, 2021
 · 
5 min read
Drug Development
Yumanity Therapeutics’ YTX-7739 Demonstrates Prevention of Motor Function Deficits in a Parkinson’s Disease Mouse Model
March 9, 2021
 · 
10 min read
Drug Development
NanoViricides, Inc. Pan-coronavirus COVID-19 Drug Candidates Are Highly Effective in Pre-clinical Animal Studies in Support of FDA Pre-IND Application
March 9, 2021
 · 
13 min read
Drug Development
GT Biopharma Announces Preclinical Results For Its ROR1 TriKE™ As A Treatment For Prostate Cancer
March 8, 2021
 · 
5 min read
Drug Development
BetterLife Enters Research Agreement with Carleton University for TD-0148A Depression Studies
March 8, 2021
 · 
4 min read
Drug Development
OncoImmunology Publishes Pre-clinical Research Showing Galectin Therapeutics’ Belapectin Galectin-3 Inhibitor Reduces Tumor Progression in Combination with Anti-OX40 Therapy
March 8, 2021
 · 
8 min read
Drug Development
Keros Therapeutics Presents Results from Preclinical Studies of KER-050 and ALK2 Inhibitors at the European School of Haematology (ESH) 2nd Translational Research E-Conference
March 5, 2021
 · 
7 min read
Drug Development
twoXAR Pharmaceuticals Presents Preclinical Data Showing Significant Efficacy and Safety of Two Novel Chronic Kidney Disease Treatment Candidates
March 4, 2021
 · 
3 min read
Load More